Monte Rosa Therapeutics (GLUE) Shares Outstanding: 2023-2025
Historic Shares Outstanding for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Sep 2025 value amounting to $2.1 million.
- Monte Rosa Therapeutics' Shares Outstanding fell 36.24% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 36.24%. This contributed to the annual value of $3.2 million for FY2024, which is 2.93% down from last year.
- Latest data reveals that Monte Rosa Therapeutics reported Shares Outstanding of $2.1 million as of Q3 2025, which was up 9.22% from $1.9 million recorded in Q2 2025.
- Over the past 5 years, Monte Rosa Therapeutics' Shares Outstanding peaked at $4.8 million during Q1 2023, and registered a low of $1.9 million during Q2 2025.
- In the last 3 years, Monte Rosa Therapeutics' Shares Outstanding had a median value of $3.3 million in 2024 and averaged $3.2 million.
- As far as peak fluctuations go, Monte Rosa Therapeutics' Shares Outstanding grew by 1.94% in 2024, and later slumped by 43.15% in 2025.
- Monte Rosa Therapeutics' Shares Outstanding (Quarterly) stood at $3.3 million in 2023, then declined by 2.93% to $3.2 million in 2024, then plummeted by 36.24% to $2.1 million in 2025.
- Its Shares Outstanding stands at $2.1 million for Q3 2025, versus $1.9 million for Q2 2025 and $2.0 million for Q1 2025.